Research Library

 
Your search returned 772 results
 
Product

Developing Public Health Regulations for Marijuana: Lessons Learned from Alcohol and Tobacco

This study offers lessons learned from alcohol and tobacco regulation. The researchers recommend that if states decide to experiment with marijuana policy, they should prevent retail price drops, limit marketing, and work hard to measure and prevent impaired driving. They also note the importance of adopting a state monopoly, restricting and monitoring licenses for use and distribution, restricting public consumption, and limiting the types of products sold.

Product Type: 
 
 
Product
 
Product
 
Product

State Foodborne Illness Reporting Laws Map

State foodborne illness laws regulate which illnesses need to be reported, the timeframe for reporting, and which agencies must then be informed of the illness and/or outbreak. This LawAtlas dataset focuses on state laws relating to foodborne illness surveillance and outbreak response, including the reporting requirements for several of the most common foodborne diseases.

Product Type: 
 
Product

Fatal Crashes from Drivers Testing Positive for Drugs in the U.S., 1993–2010

Illegal drug use is a persistent problem, prescription drug abuse is on the rise, and there is clinical evidence that drug use reduces driving performance. This study describes trends in characteristics of drivers involved in fatal motor vehicle crashes who test positive for drugs, and finds that the profile of a drugged driver has changed substantially over time. An increasing share of these drivers is now testing positive for prescription drugs, cannabis, and multiple drugs.

Product Type: 
 
 
 
Product

Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011

This study, published in the American Journal of Public Health, collected and characterized all statutes and regulations effective from 1998 through 2011 governing the operation of prescription monitoring programs. As of 2011, 10 states required PMPs to report suspicious activity to law enforcement, while only three required reporting to the patient’s physician. None required linkage to drug treatment or required all prescribers to review PMP data before prescribing. Few explicitly address data retention.

Product Type: 
 

Pages